Analysis Article • Jul 26
Have your own idea? Try our Stock Screener
French (CAC) Life Sciences Industry Analysis
UpdatedAug 30, 2026
DataAggregated Company Financials
Companies3
- 7D1.1%
- 3M13.5%
- 1Y12.4%
- YTD2.5%
The Life Sciences industry is up 1.1% in the last week, with Sartorius Stedim Biotech up 2.2%. This means that the industry has gained 12% over the past year. Earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the French Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 30 Aug 2026 | €31.9b | €10.4b | €767.3m | 26.7x | 41.6x | 3.1x |
| Tue, 28 Jul 2026 | €27.5b | €10.4b | €767.3m | 24.7x | 35.9x | 2.6x |
| Thu, 25 Jun 2026 | €28.3b | €10.3b | €689.0m | 28.1x | 41x | 2.7x |
| Sat, 23 May 2026 | €27.7b | €10.3b | €690.4m | 26.5x | 40.1x | 2.7x |
| Mon, 20 Apr 2026 | €30.7b | €10.3b | €687.9m | 29.5x | 44.7x | 3x |
| Wed, 18 Mar 2026 | €28.0b | €10.3b | €687.9m | 26.3x | 40.7x | 2.7x |
| Fri, 13 Feb 2026 | €27.8b | €10.3b | €686.1m | 27.2x | 40.5x | 2.7x |
| Sun, 11 Jan 2026 | €33.2b | €10.1b | €651.0m | 32.1x | 51x | 3.3x |
| Tue, 09 Dec 2025 | €30.9b | €10.1b | €651.0m | 26.8x | 47.4x | 3x |
| Thu, 06 Nov 2025 | €29.4b | €10.1b | €651.0m | 27.5x | 45.2x | 2.9x |
| Sat, 04 Oct 2025 | €30.6b | €10.1b | €613.3m | 29.3x | 49.9x | 3x |
| Mon, 01 Sep 2025 | €28.6b | €10.1b | €613.3m | 30.2x | 46.7x | 2.8x |
| Wed, 30 Jul 2025 | €29.4b | €10.1b | €613.3m | 31x | 47.9x | 2.9x |
| Fri, 27 Jun 2025 | €30.9b | €9.8b | €567.8m | 30.7x | 54.4x | 3.1x |
| Sun, 25 May 2025 | €28.8b | €9.8b | €567.8m | 28.6x | 50.8x | 2.9x |
| Tue, 22 Apr 2025 | €27.3b | €9.9b | €567.9m | 25.3x | 48.2x | 2.8x |
| Thu, 20 Mar 2025 | €28.6b | €9.8b | €539.0m | 25.9x | 53.1x | 2.9x |
| Sat, 15 Feb 2025 | €30.0b | €9.7b | €524.2m | 26.4x | 57.3x | 3.1x |
| Mon, 13 Jan 2025 | €28.8b | €9.5b | €494.1m | 28.3x | 58.4x | 3x |
| Wed, 11 Dec 2024 | €27.8b | €9.5b | €494.1m | 27.7x | 56.3x | 2.9x |
| Fri, 08 Nov 2024 | €26.7b | €9.5b | €494.1m | 26.4x | 53.9x | 2.8x |
| Sun, 06 Oct 2024 | €28.2b | €9.5b | €503.0m | 32x | 56.1x | 3x |
| Tue, 03 Sep 2024 | €26.8b | €9.5b | €503.0m | 30.1x | 53.3x | 2.8x |
| Thu, 01 Aug 2024 | €28.6b | €9.5b | €503.0m | 32.2x | 56.8x | 3x |
| Sat, 29 Jun 2024 | €24.0b | €9.3b | €518.8m | 35x | 46.3x | 2.6x |
| Mon, 27 May 2024 | €29.8b | €9.3b | €522.7m | 42.8x | 57.1x | 3.2x |
| Wed, 24 Apr 2024 | €32.3b | €9.3b | €522.7m | 46.3x | 61.8x | 3.5x |
| Fri, 22 Mar 2024 | €37.8b | €9.3b | €577.7m | 42.1x | 65.4x | 4x |
| Sun, 18 Feb 2024 | €35.9b | €9.3b | €735.1m | 26.9x | 48.9x | 3.9x |
| Tue, 16 Jan 2024 | €32.5b | €9.5b | €885.8m | 26.5x | 36.6x | 3.4x |
| Thu, 14 Dec 2023 | €29.9b | €9.5b | €885.8m | 25.3x | 33.7x | 3.1x |
| Sat, 11 Nov 2023 | €26.8b | €9.5b | €885.8m | 23.1x | 30.2x | 2.8x |
| Mon, 09 Oct 2023 | €31.4b | €9.7b | €1.1b | 24.7x | 29.6x | 3.2x |
| Wed, 06 Sep 2023 | €34.7b | €9.7b | €1.1b | 25.8x | 32.7x | 3.6x |
Price to Earnings Ratio
32.7x
Current Industry PE
- There are only 3 companies in the French Life Sciences industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 10% per year over the last three years.
- Meanwhile revenues for these companies have grown 2.4% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | -0.74% | |
| Healthcare | -1.36% | |
| Life Sciences | 1.06% | |
| Clinical Research and Equipment | 1.06% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIM Sartorius Stedim Biotech | €197.70 | 2.2% +€408.6m | 13.0% | PE65.7x | |
| ALECR Eurofins-Cerep | €18.20k | 11.7% +€9.6m | -1.1% | PE19.2x |